Chronic agonist treatment converts antagonists into inverse agonists at δ-opioid receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 3, 2002, Pages 1070-1079

  Liu, Jing Gen ^a   Prather, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MORPHINE; MU OPIATE RECEPTOR; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; N,N DIALLYLTYROSYLGLYCYL ALPHA (2 AMINOETHYLTHIO)HYDROCINNAMOYLLEUCINE; NALOXONE; NALTRIBEN; NALTRINDOLE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; ANIMALS; CELL LINE; CELL MEMBRANE; DRUG TOLERANCE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MORPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 0036721027     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.035964     Document Type: Article

References (38)

1. Sodium ions increase the binding of the antagonist peptide ICI 174864 to the δ-opiate receptor
2. Role of aromatic transmembrane residues of the δ-opioid receptor in ligand recognition
3. 3): Elevated basal signalling activity
4. The efficacy of δ-opioid receptor-selective drugs
5. 32 P]GTP labeling of multiple G protein α subunits
6. 5]-enkephalin- μ-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation
7. The μ-opioid receptor down-regulates differently from the δ-opioid receptor: Requirement of a high affinity receptor/G protein complex formation
8. Agonist-induced modulation of inverse agonist efficacy at the β-adrenergic receptor
9. Differential regulation by guanine nucleotides of opioid agonist and antagonist receptor interactions
10. Cellular aspects of opioid tolerance and dependence
11. Drug efficacy at guanine nucleotide-binding regulatory protein linked receptors: Thermodynamic interpretations of negative antagonism and of receptor activity in the absence of ligand
12. ICI 174864 is a highly selective antagonist for the opioid δreceptor
13. Direct dependence studies in rats with agents selective for different types of opioid receptor
14. Morphine activates opioid receptors without causing their rapid internalization
15. N-Benzylnaltrindoles as long-acting δ-opioid receptor antagonists
16. μ- and δ-opioid receptors are differentially desensitized by the coexpression of β-adrenergic receptor kinase 2 and β-arrestin 2 in Xenopus oocytes
17. Molecular mechanisms and regulation of opioid receptor signaling
18. Constitutive activity of receptors coupled to guanine-nucleotide regulatory proteins
19. 5]enkephalin
20. Chronic exposure to μ-opioid agonists produces constitutive activation of μ-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment
21. Agonist, antagonist and inverse agonist characteristics of TIPP, a selective δ-opioid receptor ligand
22. Agonist activity of the δ-antagonists TIPP and TIPP[psi] in cellular models expressing endogenous and transfected δ-opioid receptors
23. Regulation of spontaneous activity of the δ-opioid receptor: Studies of inverse agonism in intact cells
24. Constitutive activity of the δ-opioid receptor expressed in C6 glioma cells: Identification of non-peptide δ-inverse agonists
25. Drug addiction: A model for the molecular basis of neural plasticity
26. 3 cells
27. A highly selective δ1-opioid receptor antagonist: 7-benzylidenenaltrexone
28. Design of peptidomimetic δ opioid receptor antagonists using the message-address concept
29. Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density
30. 2+ channels in transfected rat pituitary cells
31. Opioid Analgesics and Antagonists
32. δ-opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy
33. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance
34. Selective antagonists at the opiate 5-receptor
35. Chronic opioid treatment may uncouple opioid receptors and G-proteins: Evidence from radiation inactivation analysis
36. Constitutive μ-opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence
37. 3) in morphine-pretreated cells
38. Agonist-, antagonist-, and inverse agonist-regulated trafficking of the δ-opioid receptor correlates with, but does not require, G protein activation